4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000002
Chief Financial Officer sold 2,932 shares at $27.09 ($79,428)
- Chief Financial Officer acquired 6,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones Cecilia Chief Financial Officer | 2025-12-30 | Option exercise 10b5-1 | +6,000 | 40,326 | D: show line 1 in the form | ||
| Jones Cecilia Chief Financial Officer | 2025-12-30 | Sale 10b5-1 | −2,932 | $27.09 | $79,428 | 37,394 | D: show line 2 in the form |
| Open-market sales · 2,932 sh · avg $27.09 · $79,428 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones Cecilia Chief Financial Officer | 2025-12-30 | Option exercise · Performance share units 10b5-1 | −6,000 | 0 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1767402864.xml…